AEON Biopharma Inc (AMEX:AEON) traded at $0.74 at last check on current trade day and made an upward move of 4.00% on its previous day’s price.
Looking at the stock we see that its previous close was $0.71 and the beta (5Y monthly) reads 0.568 with the day’s price range being $0.7199 – $0.79. The company has a trailing 12-month PE ratio of 0.00. In terms of its 52-week price range, AEON has a high of $269.28 and a low of $0.38. The company’s stock has gained about 34.12% over that past 30 days.
AEON Biopharma Inc has a market cap of $8.32 million and is expected to release its quarterly earnings report on 2025-Mar-24.
On the other hand, looking at the outlook for the AEON stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Sell.
Based on estimates by 1 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the AEON Biopharma Inc (AEON) stock as a Hold, while 1 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is -0.79% off its SMA20 and 28.22% from its 50-day simple moving average. The RSI (14) is pointing at 50.72 while the volatility over the past week is 4.59% and jumps to 7.13% over the past one month.
Coming back to AEON Biopharma Inc (AMEX:AEON), we note that the average 3-month trading volume was 898.63K, while that of the preceding 10-day period stands at 0.36 million. Current shares outstanding are 10.54 million.
The insiders hold 16.57% of the company’s shares while institutions hold 13.50%. The data shows that short shares as of 2025-05-30, stood at 1.18 million at a short ratio of 0.69. This represents a 1045.00 short interest in shares outstanding on 2025-05-30. Shares short rose in May from the previous month at 68941.0. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -99.24% down in year-to-date price movement.
